Literature DB >> 14602444

The trypanosomiases.

Michael P Barrett1, Richard J S Burchmore, August Stich, Julio O Lazzari, Alberto Carlos Frasch, Juan José Cazzulo, Sanjeev Krishna.   

Abstract

The trypanosomiases consist of a group of important animal and human diseases caused by parasitic protozoa of the genus Trypanosoma. In sub-Saharan Africa, the final decade of the 20th century witnessed an alarming resurgence in sleeping sickness (human African trypanosomiasis). In South and Central America, Chagas' disease (American trypanosomiasis) remains one of the most prevalent infectious diseases. Arthropod vectors transmit African and American trypanosomiases, and disease containment through insect control programmes is an achievable goal. Chemotherapy is available for both diseases, but existing drugs are far from ideal. The trypanosomes are some of the earliest diverging members of the Eukaryotae and share several biochemical peculiarities that have stimulated research into new drug targets. However, differences in the ways in which trypanosome species interact with their hosts have frustrated efforts to design drugs effective against both species. Growth in recognition of these neglected diseases might result in progress towards control through increased funding for drug development and vector elimination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602444     DOI: 10.1016/S0140-6736(03)14694-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  253 in total

Review 1.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

Review 2.  Antimicrobial peptide killing of African trypanosomes.

Authors:  J M Harrington
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

3.  Antagonic activities of Trypanosoma cruzi metacaspases affect the balance between cell proliferation, death and differentiation.

Authors:  M Laverrière; J J Cazzulo; V E Alvarez
Journal:  Cell Death Differ       Date:  2012-03-09       Impact factor: 15.828

4.  A novel phosphatase cascade regulates differentiation in Trypanosoma brucei via a glycosomal signaling pathway.

Authors:  Balázs Szöor; Irene Ruberto; Richard Burchmore; Keith R Matthews
Journal:  Genes Dev       Date:  2010-06-15       Impact factor: 11.361

5.  Symmetrical choline-derived dications display strong anti-kinetoplastid activity.

Authors:  Hasan M S Ibrahim; Mohammed I Al-Salabi; Nasser El Sabbagh; Neils B Quashie; Abdulsalam A M Alkhaldi; Roger Escale; Terry K Smith; Henri J Vial; Harry P de Koning
Journal:  J Antimicrob Chemother       Date:  2010-11-14       Impact factor: 5.790

6.  An Aromatic Diamidine That Targets Kinetoplast DNA, Impairs the Cell Cycle in Trypanosoma cruzi, and Diminishes Trypomastigote Release from Infected Mammalian Host Cells.

Authors:  Richard M B M Girard; Marcell Crispim; Ivana Stolić; Flávia Silva Damasceno; Marcelo Santos da Silva; Eizabeth Mieko Furusho Pral; Maria Carolina Elias; Miroslav Bajić; Ariel Mariano Silber
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  A targeted delivery strategy for the development of potent trypanocides.

Authors:  Heeren M Gordhan; Jillian E Milanes; Yijian Qiu; Jennifer E Golden; Kenneth A Christensen; James C Morris; Daniel C Whitehead
Journal:  Chem Commun (Camb)       Date:  2017-07-20       Impact factor: 6.222

8.  Two trypanosome-specific proteins are essential factors for 5S rRNA abundance and ribosomal assembly in Trypanosoma brucei.

Authors:  Kristina M Hellman; Martin Ciganda; Silvia V Brown; Jinlei Li; William Ruyechan; Noreen Williams
Journal:  Eukaryot Cell       Date:  2007-08-22

9.  Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.

Authors:  Sonya C Tang; Theresa A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.

Authors:  Liam J Morrison; Sarah McLellan; Lindsay Sweeney; Chi N Chan; Annette MacLeod; Andy Tait; C Michael R Turner
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.